Research Publications

Total Publications = 55, Total google Citations: 1699, h-Index=23, i10-Index=29
Link to: Total citations of Research publication: 1677 at Google Scholar
  • Bhargava D, Kumar A, Vidua RK. Original study on cadavers for estimating time since death by measuring biochemical parameters in blood and Muscle. American Journal of Forensic medicine and Pathology. 2023. (Accepted)
  • Joshi B, Shankar U, Vishwakarma S, Kumar A, Kumar A, Joshi D, Joshi A. Multifunctional Ultrasmall Theranostic Nanohybrids Developed by Ultrasonic Atomizer for Drug Delivery and Magnetic Resonance Imaging. ACS Appl. Bio Mater. 2023. doi.org/10.1021/acsabm.3c00151
  • Joshi B, Kaur J, Khan E, Vishwakarma S, Kumar A, Joshi D, Kumar A*, Joshi A. Alginate-based ‘nano-micro’ hybrid matrices developed using ultrasonic atomization for co-delivery of chemotherapeutic drugs against superficial tumors. Journal of Drug Delivery Science and Technology. 2023 (Accepted) Impact Factor 5.0.* Co-corresponding author
  • Singh H, Khurana A, Kumar A and Saluja R. Himadri Serum Levels of Interleukin-33, soluble ST2 and IgE in patients with Asthma: A case-control study. Journal of Asthma (Revision).
  • Tiwari S, Pandey R, Kumar V, Das S, Gupta V, Vishwakarma S, Nema R, Hashmi S, Kumar A. miRNA-146a rs2910164 Single Nucleotide Polymorphism is associated with increased predisposition to Oral Squamous Cell Carcinoma in Central India Population. Cancer Biomarkers 2023 (under revision).
  • Kumari A, Jha A, Tiwari A, Nath N, Kumar A, Nagini S, Mishra R. Role and regulation of GLUT1/ 3 during oral cancer progression and therapy resistance. Archives of Oral Biology. 2023; 150:105688. (PMID: 36989865)
  • Joshi S, Pandey R, Kumar A, Gupta V, and Arya N. Targeted blockade of interleukin-8 negates metastasis and chemoresistance via Akt/Erk-NFκB axis in oral cancer. Cytokine 2023 Apr 21;166:156155. doi: 10.1016/j.cyto.2023.156155
  • Kumari R, Tiwari S, Atlani M, Anirudhan A, Goel SK, Kumar A. Association of Single nucleotide polymorphisms in KCNA10 and SLC13A3 genes with the susceptibility to Chronic Kidney Disease of unknown etiology in central Indian patients. Biochemical Genetics. 2023 Jan 25. doi: 10.1007/s10528-023-10335-7. Epub ahead of print. PMID: 36696070
  • Chatterjee A, Rakshit S, Sanmugam G, Mohanty LM, Kumar A, Harihar S, Sarkar K. Neem Leaf Glycoprotein mediated epigenetic modification in Oral Squamous Cell Carcinoma. Phytomedicine Plus. 2023; 3(1)100400
  • Khurana S, Singh AP, Kumar A, Nema R. Prognostic value of AKT isoforms in non-small cell lung adenocarcinoma[J]. The Journal of Biomedical Research. 2022 Nov 10:1-4. doi: 10.7555/JBR.36.20220138
  • Shivhare A, Jain A, Sharma JP, Kaushal A, Kumar H, Kumar A. Intravascular volume status and stress markers in patients observing long and short duration of fasting: A prospective single blinded observational study. Journal of Clinical Anesthesia. 2022; Nov 3:110992. doi: 10.1016/j.jclinane.2022.110992. Epub ahead of print. PMID: 36336510. (IF 9.3)
  • Shivhare A, Jain A, Sharma JP, Kaushal A, Kumar H, Kumar A. Intravascular volume status and stress markers in patients observing long and short duration of fasting: A prospective single blinded observational study. Journal of Clinical Anesthesia. 2022; Nov 3:110992. doi: 10.1016/j.jclinane.2022.110992. Epub ahead of print. PMID: 36336510. (IF 9.3)
  • Jain S, Singh AP, Kumar A, Saluja R and Nema R. Stem cells Research prospects towards precision medicine. Bratislava Medical Journal (Bratisl Lek Listy) 2022;123(11):795-805 doi:10.4149/BLL_2022_128
  • Atlani M, Kumar A, Pakhare A P, Potential Association of Hypernatremia With Mortality in Patients With Acute Kidney Injury and COVID-19. Cureus. 2022 14(7): e27530. doi:10.7759/cureus.27530
  • de la garza-Rodea A, Moore SA, Zamora-Pineda J, Hoffman EH, Mistry K, Kumar A, Strober JB, Zhao P, Suh JH, Saba JD. Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice. International Journal of Molecular Sciences. 2022; 23(14): 7579 https://doi.org/10.3390/ijms23147579 (IF 5.5)
  • Tiwari S, Goel G, Kumar A. Natural and genetically-modified animal models to investigate pulmonary and extrapulmonary manifestations of COVID-19. International Reviews of Immunology. 2022 (June). 10.1080/08830185.2022.2089666
  • Vishwakarma S, Joshi D, Singh R, Singhal R, Kapoor N, Goel SK, Kumar A. Downregulation of Lipid Phosphate Phosphatase 3 correlates with Tumor-Infiltrating Immune Cells in Oral Cancer. Cureus 2022 Mar 27;14(3):e23553 DOI: 10.21203/rs.3.rs-1043910/v1
  • Sadique MA, Yadav S, Ranjan P, Khan MA, Kumar A, Khan R. Rapid Detection of SARS-CoV-2 using Graphene-based IoT Integrated Advanced Electrochemical Biosensor. Material Letters. 2021; 305: 130824. (IF 3.4) (Highlighted by Nature India https://www.nature.com/articles/d44151-022-00049-x)
  • Tomar MS, Kumar A, Srivastava C, Shrivastava A. Elucidating the mechanism of Temozolomide Resistance in gliomas and the strategies to overcome the resistance. Biochim Biophys Acta Rev Cancer. 2021 Aug 20;1876(2):188616. (IF 11.4)
  • Chaudhary P, Goyal A, Pakhare A, Goel SK, Kumar A, Reddy MA, Anoohya V. Metabolic syndrome in non-obese patients with OSA: learning points of a cross-sectional study from a tertiary care hospital in Central India. Sleep Breath. 2021 Jul 20:1–8. doi: 10.1007/s11325-021-02401-4. PMID: 34283339 (IF 2.6)
  • Chandel V, Maru S, Kumar A, Kumar A, Sharma A, Rathi B, Kumar D. Role of Monocarboxylate Transporters in Head and Neck Squamous Cell Carcinoma. Life Sciences. 2021;279:119709 https://doi.org/10.1016/j.lfs.2021.119709 (IF 6.7)
  • Nema R, Patel P, Kumar A. Prognostic role of receptor tyrosine kinase–like orphan receptors in intestinal-type gastric cancer. Asian Pacific Journal of Cancer Prevention. 2021 Jul 1;22(7):2125-2134 (IF 1.6)
  • Vishwakarma S, Arya N and Kumar A. Regulation of tumor immune microenvironment by sphingolipids and lysophosphatidic acid. Current Drug Targets. 2022;23(6):559-573. doi: 10.2174/1389450122666211208111833. PMID: 34879798
  • Nema R, and Kumar A. Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells. Frontiers in Molecular Biosciences. 2021;8:584 (IF 5.2)
  • Chaudhary P, Goyal A, Goel SK, Kumar A, Chaudhary S, Kirti Keshri S, Phadke Subhedar R. Women with OSA have higher chances of having metabolic syndrome than men: effect of gender on syndrome Z in cross sectional study. Sleep Med. 2021 Jan 2;79:83-87. (IF 3.6)
  • Nema R, Shrivastava A and Kumar A. Prognostic role of lipid phosphate phosphatases in non-smoker, lung adenocarcinoma patients. Computers in Biology and Medicine 2021;129: 104141 (IF 4.5) doi.org/10.1016/j.compbiomed.2020.104141.
  • Vishwakarma S, Pandey R, Singh R, Gothalwal R, Kumar A. Expression of H19 long noncoding RNA is down-regulated in Oral Squamous Cell Carcinoma. Journal of Biosciences 2020; 45:145 (IF 1.8)
  • Nema S, Kallianpur S, Kumar A, Nema R,Vishwakarma S, Nema SK. Do patients with oral squamous cell carcinoma express receptor tyrosine kinase‐like orphan receptor 1? Results of an observational study. J Oral Maxillofac Pathol 2021;25:105-9
  • Kumar A, Arya N (2018) Mfsd2b, a Novel Sphingosine-1-Phosphate Transporter: Implication in Cancer Therapeutics. Journal of Clinical and Experimental Oncology 2018; 7:2. doi: 10.4172/2324-9110.1000e113
  • Kumar A, Zamora-Pineda J, Degagné E and Saba JD. S1P lyase regulation of thymic egress and oncogenic inflammatory signaling. Mediators of Inflammation. 2017;2017:7685142. (IF 4.7)
  • Saluja R, Kumar A, Jain M, Goel SK, Jain A. Potential Role of Sphingosine-1-Phosphate in Mast Cell Functions and Asthma and its Regulation by Non Coding RNA. Frontiers in Immunology 2017 May 22;8:587 (Impact Factor 6.7)
  • Vishwakarma S, Agarwal R, Goel SK, Panday RK, Singh R, Sukumaran R, Khare S, Kumar A. Altered expression of Sphingosine-1-Phosphate metabolizing enzymes in oral cancer correlate with clinicopathological attributes. Cancer Investigation 2017 Feb 7;35(2):139-141 (IF 2.2)
  • Kumar A, Zamora-Pineda J, Suh JH, Zhang M, Saba JD. Dendritic cell sphingosine-1-phosphate lyase regulates thymic egress. J Exp. Med. 2016 Oct 17 213(12): 2773-2791 DOI: 10.1084/jem.20160287 (IF 14.3).
  • Nema R, Vishwakarma S, Agarwal R, Panday RK, Kumar A. Emerging Role of Sphingosine-1-Phosphate Signaling in Head and Neck Squamous Cell Carcinoma. OncoTargets and Therapy 2016; May 31;9:3269-80 (Impact Factor 3.8)
  • Kumar A and Saba JD. Regulation of Leukocyte trafficking by Sphingosine-1-Phosphate. Cell Mol Biol (OMICS). 2015;61(2):121. doi: 10.4172/1165-158X.1000121 (Impact Factor 5.68)
  • Nema R, Kumar A. Regulation of Mitochondrial Function by Bioactive Sphingolipids. Cell Biology. Special Issue: Mitochondria: Implications in Human Health and Diseases. 2015 Feb; 3(2-1):1-7doi: 10.11648/j.cb.s.2015030201.11
  • Degagné E, Pandurangan AK, Bandhuvula P, Kumar A, Eltnawy A, Zhang M, Yoshinaga Y, Nefedov M, de Jong P, Fong LG, Young SG, Bittman R, Ahmedi Y, Saba JD. Sphingosine-1-phosphate lyase downregulation promotes colon carcinogenesis through STAT3-activated miRNAs. J Clin. Invest. 2014 Dec;124(12):5368-84. (Impact Factor 14.8)
  • de la Garza-Rodea AS, Baldwin D, Oskouian B, Place Robert, Bandhuvula P, Kumar A, and Saba JD. S1P lyase regulates myogenic differentiation via S1PR-mediated effects on myogenic miRNA expression. FASEB Journal 2014 Jan;28(1):506-19. (Impact Factor 5.0)
  • Kumar A, Pandurangan AK, Lu F, Fyrst F, Zhang M, Byun HS, Bittman R, and Saba JD. Chemopreventive Sphingadienes Downregulate Wnt Signaling in Human Colon Cancer Cells and Intestinal Tissues of ApcMin/+ Mice. Carcinogenesis 2012 Sep;33(9):1726-35. (Impact Factor 5.3)
  • Borowsky AD, Bandhuvula P, Kumar A, Yoshinaga Y, Nefedov M, Fong LG, Zhang M, Baridon B, Dillard L, de Jong P, Young SG, West DB, Saba JD. Sphingosine-1-phosphate lyase expression in embryonic and adult murine tissues. J Lipid Res. 2012 Sep; 53(9): 1920-31. (Impact Factor 5.9)
  • Upadhyaya P, Kumar A, Byun HS, Bittman R, Saba JD, and Hecht SS. The sphingolipid degradation product trans-2-hexadecenal forms adducts with DNA. Biochemical and Biophysical Research Communications 2012 Jul 20;424(1):18-21. (Impact Factor 3.5)
  • Loh KC, Leong WI, Carlson ME, Oskouian B, Kumar A, Fyrst F, Zhang M, Proia RL, Hoffman E and Saba JD. Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through an S1PR2/STAT3 signaling pathway. PLoS One 2012, 7(5) e37218 (Impact Factor 3.2)
  • Smith, G.S.; Kumar, A.; Saba, J.D. Sphingosine Phosphate Lyase Regulates Murine Embryonic Stem Cell Proliferation and Pluripotency through an S1P2/STAT3 Signaling Pathway. Biomolecules 2013, 3, 351-368 (Impact Factor 4.6)
  • Kumar A, Byun HS, Bittman R and Saba JD. The sphingolipid degradation product trans-2-hexadecenal induces cytoskeletal reorganization and apoptosis in a JNK-dependent manner. Cellular Signaling 2011 Jul;23(7):1144-52. (Impact Factor 4.0)
  • Kumar A, Oskouian B, Fyrst H, Zhang M, Paris F and Saba JD. S1P Lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism. Cell Death & Disease 2011 2, e119 (Impact Factor 8.4)
  • Tandon A, Shrivastava A, Kumar A, Prayaga AK, Sundaram C, Godbole MM. Sodium Iodide Symporter, Estrogen Receptor and Progesterone Receptor Expression in Carcinoma Breast - an Immunohistochemical Analysis. Indian J Pathology and Microbiology. 2011, 54 (4) 745-751. (Impact Factor 0.7)
  • Kumar A and Saba JD. Lyase to live by: Sphingosine phosphate lyase as a therapeutic target. Expert Opin Ther Targets. 2009 Aug;13(8):1013-25. (Impact Factor 6.9)
  • Sinha RA, Pathak A, Kumar A, Tiwari M, Shrivastava A, Godbole MM. Enhanced neuronal loss under perinatal hypothyroidism involves impaired neurotrophic signaling and increased proteolysis of p75(NTR). Mol Cell Neurosci. 2009 Mar;40(3):354-64 (Impact Factor 3.9)
  • Tiwari M, Bajpai VK, Sahasrabuddhe AA, Kumar A, Sinha RA, Behari S, Godbole MM. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances apoptosis in malignant glioma cells. Carcinogenesis. 2008 Mar;29(3):600-9. (Impact Factor 5.3)
  • Kumar A, Sinha RA, Tiwari M, Singh R, Koji T, Manhas N, Rastogi L, Pal L, Shrivastava A, Sahu RP, Godbole MM. Hyperthyroidism induces apoptosis in rat liver through activation of death receptor-mediated pathways. Journal of Hepatology 2007; 46(5):888-898. (Impact Factor 25.0)
  • Tiwari M, Kumar A, Sinha RA, Shrivastava A, Balapure AK, Sharma R, Bajpai VK, Mitra K, Babu S, and Godbole MM. Mechanism of 4-HPR induced apoptosis in glioma cells: Evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress. Carcinogenesis 2006; 27(10):2047-2058. (Impact Factor 5.3)
  • Kumar A, Sinha RA, Tiwari M, Pal L, Shrivastava A, Singh R, Kumar K, Gupta SK, and Godbole MM. Increased pro-Nerve Growth Factor and p75NTR levels in developing hypothyroid rat cerebral cortex are associated with enhanced apoptosis. Endocrinology 2006; 147(10):4893-4903. (Impact Factor 4.2)
  • Shrivastava A, Tiwari M, Sinha RA, Kumar A, Balapure AK, Bajpai VK, Sharma R, Mitra K, Tandon A, and Godbole MM Molecular iodine induces caspase-independent apoptosis in human breast carcinoma cells involving mitochondria-mediated pathway. Journal of Biological Chemistry 2006; 281(28): 19762-19771. (Impact Factor 5.1)
  • Upadhyay G, Singh R, Kumar A, Kumar S, Kapoor A, Godbole MM. Severe hyperthyroidism induces mitochondria-mediated apoptosis in rat liver. Hepatology 2004; 39(4):1120-1130. (Impact Factor 17.4)
  • Singh R, Upadhyay G, Kumar S, Kapoor A, Kumar A, Tiwari M, Godbole MM. Hypothyroidism alters the expression of Bcl-2 family genes to induce enhanced apoptosis in the developing cerebellum. J Endocrinology 2003 176(1):39-46. (Impact Factor 4.2)
  • Kumar A, Dharmadheeran JS, Kumar A, Thakral SS. Strain Characterization of vp1/vp2 gene of Canine Parvovirus of Indian origin. Journal of Applied Animal Research, 2004;25: 56-60. (Impact Factor 1.9)
Scroll to Top